Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Al-Sanea

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Molecular Cancer|August 3, 2010
Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterationsPrashant Bavi, Sarita E Prabhakaran, Jehad Abubaker, et al.
Cancer|July 29, 2015
Molecular markers and pathway analysis of colorectal carcinoma in the Middle EastShaham Beg, Abdul K Siraj, Sarita Prabhakaran, et al.
Cancer|February 26, 2015
Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancerAbdul K Siraj, Sarita Prabhakaran, Prashant Bavi, et al.
The American Journal of Pathology|April 26, 2011
Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinomaPrashant Bavi, Shahab Uddin, Maqbool Ahmed, et al.
Molecular Cancer Therapeutics|May 5, 2019
TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRCAbdul K Siraj, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.
Journal of Clinical Pathology|August 3, 2006
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya, Hedvika Novotny, Prashant Bavi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2019
APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapyAbdul K Siraj, Sandeep Kumar Parvathareddy, Poyil Pratheeshkumar, et al.
Human Genetics|October 5, 2017
Expanding the spectrum of germline variants in cancerAbdul K Siraj, Tariq Masoodi, Rong Bu, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Cancer|August 3, 2010
Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterationsPrashant Bavi, Sarita E Prabhakaran, Jehad Abubaker, et al.
Cancer|July 29, 2015
Molecular markers and pathway analysis of colorectal carcinoma in the Middle EastShaham Beg, Abdul K Siraj, Sarita Prabhakaran, et al.
Cancer|February 26, 2015
Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancerAbdul K Siraj, Sarita Prabhakaran, Prashant Bavi, et al.
The American Journal of Pathology|April 26, 2011
Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinomaPrashant Bavi, Shahab Uddin, Maqbool Ahmed, et al.
Molecular Cancer Therapeutics|May 5, 2019
TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRCAbdul K Siraj, Poyil Pratheeshkumar, Sasidharan Padmaja Divya, et al.
Journal of Clinical Pathology|August 3, 2006
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya, Hedvika Novotny, Prashant Bavi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2019
APC truncating mutations in Middle Eastern Population: Tankyrase inhibitor is an effective strategy to sensitize APC mutant CRC To 5-FU chemotherapyAbdul K Siraj, Sandeep Kumar Parvathareddy, Poyil Pratheeshkumar, et al.
Human Genetics|October 5, 2017
Expanding the spectrum of germline variants in cancerAbdul K Siraj, Tariq Masoodi, Rong Bu, et al.
Pageof 3